AstraZeneca Gets CDSCO Panel Nod To study Baxdrostat Tablets and Dapagliflozin Tablets Dr. Divya Colin7 Feb 2025 6:00 PM ISTNew Delhi: AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal To Study antihypertensive drug Baxdrostat Dr. Divya Colin29 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the pharmaceutical...
50% of trial sites should be Govt sites, more subjects should be enrolled from Govt sites: CDSCO panel tells AstraZeneca on Baxdrostat study Dr. Divya Colin15 Aug 2024 5:45 PM ISTNew Delhi: In line with the drug major AstraZeneca's protocol amendment proposal to study the cardiovascular drug Baxdrostat, the Subject Expert...
AstraZeneca gets CDSCO panel Nod To study antihypertensive drug Baxdrostat Dr. Divya Colin9 Dec 2023 9:34 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Baxdrostat use for BP control in patients with uncontrolled hypertension: HALO trial provides insight Medha Baranwal14 March 2023 11:30 AM ISTUSA: Recent data from the HALO trial showed that aldosterone synthase inhibition with baxdrostat was well-tolerated among patients with hypertension...
AstraZeneca concludes acquisition of CinCor Pharma Ruchika Sharma26 Feb 2023 2:30 PM ISTUK: AstraZeneca has announced the successful completion of the acquisition of CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical...
Medical Bulletin 10/November/2022 Dr Rashi Prakash10 Nov 2022 2:47 PM ISTHere are the top medical news for the day:Artificial intelligence could help ease strain on hospitalsTuberculosis and pneumonia are potentially...
New drug can successfully treat patients typically resistant to high blood pressure treatment Dr Rashi Prakash10 Nov 2022 9:45 AM ISTHigh blood pressure is the main cause of strokes, and a common cause of heart attacks and kidney failure. In most people with the condition, the...
New drug, baxdrostat, offers hope to patients resistant to high blood pressure treatment: Phase 2 trial Dr Kartikeya Kohli9 Nov 2022 11:45 AM ISTThe highest dose of oral medication (Baxdrostat) in patients with treatment-resistant hypertension reduced blood pressure by 20 points.UK: A new class...
